Skip to main content

Table 1 Patient characteristics

From: Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas

Case no.

Age (y) /Gender

Site

INSS

N-myc amp.

Risk

Residual tumor status

CTV

(ml)

Prescribed dose [Gy (RBE)]

1

4/F

Rt. Retroperitoneum

4

-

High

Inoperable

147

41.4

2

11/M

Upper abdomen Mediastinum

4

-

High

Recurrence

105

36

3

5/M

Upper abdomen Mediastinum

4

-

High

Complete resection

172

21.6

4

2/F

Lt. Adrenal

4

48

High

Gross total resection

464

21.6

5

2/F

Lt. Adrenal

2A

217

High

Subtotal resection

108

36